DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/2rkk7c/menopausal_hot)
has announced the addition of the “Menopausal
Hot Flashes – Pipeline Review, H2 2015” report to their
This report provides comprehensive information on the therapeutic
development for Menopausal Hot Flashes, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Menopausal Hot Flashes and special features on late-stage and
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
- Menopausal Hot Flashes Overview
- Therapeutics Development
- Pipeline Products for Menopausal Hot Flashes – Overview
- Pipeline Products for Menopausal Hot Flashes – Comparative Analysis
- Menopausal Hot Flashes – Therapeutics under Development by Companies
Menopausal Hot Flashes – Therapeutics under Investigation by
- Menopausal Hot Flashes – Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Menopausal Hot Flashes – Products under Development by Companies
Menopausal Hot Flashes – Products under Investigation by
- Menopausal Hot Flashes – Companies Involved in Therapeutics Development
- Amgen Inc.
- EndoCeutics, Inc.
- Pantarhei Bioscience BV
- Pherin Pharmaceuticals, Inc.
- Pivot Pharmaceuticals Inc
- Radius Health, Inc.
For more information visit http://www.researchandmarkets.com/research/2rkk7c/menopausal_hot
Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716